2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Group B Streptococcus: new trials by email Literature Review of Group B Streptococcus trials Research Report on Group B Streptococcus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women Group B streptococcus (GBS) vaccine- low dose, Group B streptococcus (GBS) vaccine- High dose, Placebo- Saline - Group B Streptococcus | Phase 1 | Completed | Novartis Vaccines | 678 | 2010-05-01 | 2017-05-15 |
| Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines GBS III-TT-SSI, GBS III-TT-MPHL - Bacterial Infections, Group B Streptococcus | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 65 | 2010-08-27 |
Bacterial Infections (1) · Disease (1) · Guillain-Barre Syndrome (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections and Mycoses (1) · Chronic Disease (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Infections (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Nervous System Diseases (1) · Polyneuropathies (1) · Polyradiculoneuropathy (1)
Vaccines (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Novartis Vaccines (1)
Belgium (1) · United States (1)